Literature DB >> 6458421

The effects on atrial electrophysiology and structure of surgically induced right atrial enlargement in dogs.

P A Boyden, B F Hoffman.   

Abstract

We evaluated the relationship between susceptibility to arrhythmias caused by right atrial (RA) enlargement and alterations in transmembrane potentials and ultrastructure. RA enlargement was produced in eight dogs (TI) by excising the septal cusp of the tricuspid valve through a right atriotomy and constricting the pulmonary artery. This procedure resulted in RA dilation and hypertrophy. Four sham-operated dogs (S) also were studied. Neither TI nor S dogs developed spontaneous atrial arrhythmias. Atrial overdrive (OD) and premature stimulation (PS) were used to initiate and terminate arrhythmias. At 2 weeks and for 20 to 30 weeks after surgical preparation, TI dogs were more susceptible to arrhythmias than S dogs. The duration of arrhythmias exceeded 10 minutes more often in TI dogs than in S dogs. Sixty-one percent of all arrhythmias in the TI dogs had rates of 320-450 impulses/min, and electrogram and ECG characteristics of atrial flutter (type II rhythm), whereas no S dogs developed rhythms with these slower rates. The type II rhythms were persistent, 30% lasting longer than 30 minutes, while 22% lasted more than 60 minutes. Transmembrane potentials recorded in vitro from the RA free wall of TI dogs, and responses to norepinephrine and acetylcholine were not different from control. Histological and ultrastructural studies on TI atria showed hypertrophy of fibers and some increase in connective tissue between cells. These results suggests that altered susceptibility to long-lasting arrhythmias need not be associated with significant abnormalities of cellular electrophysiology.

Entities:  

Mesh:

Year:  1981        PMID: 6458421     DOI: 10.1161/01.res.49.6.1319

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  15 in total

Review 1.  Mechanisms underlying the development of atrial arrhythmias in heart failure.

Authors:  Vias Markides; Nicholas S Peters
Journal:  Heart Fail Rev       Date:  2002-07       Impact factor: 4.214

2.  Electrophysiological mechanisms of atrial flutter.

Authors:  Ching-Tai Tai; Shin-Ann Chen
Journal:  Indian Pacing Electrophysiol J       Date:  2006-04-01

Review 3.  Sinus Node Dysfunction in Atrial Fibrillation: Cause or Effect?

Authors:  Anna Kezerashvili; Andrew K Krumerman; John D Fisher
Journal:  J Atr Fibrillation       Date:  2008-09-16

Review 4.  Atrial Septal Defect and Atrial Fibrillation: The Known and Unknown.

Authors:  George E Blake; Dhanunjaya Lakkireddy
Journal:  J Atr Fibrillation       Date:  2008-09-16

Review 5.  Atrial Remodeling And Atrial Fibrillation: Mechanistic Interactions And Clinical Implications.

Authors:  Bandar Al Ghamdi; Walid Hassan
Journal:  J Atr Fibrillation       Date:  2009-06-01

Review 6.  Mechanisms for cardiac arrhythmias.

Authors:  B F Hoffman; K H Dangman
Journal:  Experientia       Date:  1987-10-15

7.  Transverse tubules are a common feature in large mammalian atrial myocytes including human.

Authors:  M A Richards; J D Clarke; P Saravanan; N Voigt; D Dobrev; D A Eisner; A W Trafford; K M Dibb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-12       Impact factor: 4.733

8.  A new role for extracellular Ca2+ in gap-junction remodeling: studies in humans and rats.

Authors:  S Dhein; N Duerrschmidt; A Scholl; A Boldt; J S Schulte; B Pfannmüller; D Rojas-Gomez; A Scheffler; J-A Haefliger; N Doll; F-W Mohr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-16       Impact factor: 3.000

9.  Early and late arrhythmias after the Fontan operation: predisposing factors and clinical consequences.

Authors:  M Gewillig; R K Wyse; M R de Leval; J E Deanfield
Journal:  Br Heart J       Date:  1992-01

Review 10.  Atrial remodelling in atrial fibrillation: CaMKII as a nodal proarrhythmic signal.

Authors:  Olurotimi O Mesubi; Mark E Anderson
Journal:  Cardiovasc Res       Date:  2016-01-13       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.